Exeltis USA, Inc. v. Lupin Ltd.

• Court: Court of Appeals for the Federal Circuit
• Decided: September 29, 2025
• Docket: 25-1239
• Status: Unpublished

Opinion

Case: 25-1239 Document: 25 Page: 1 Filed: 09/29/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

EXELTIS USA, INC., LABORATORIOS LEON FARMA, S.A., CHEMO IBERICA, S.A., CHEMO RESEARCH, S.L., Plaintiffs-Appellees

v.

LUPIN LTD., LUPIN PHARMACEUTICALS, INC., Defendants-Appellants ______________________

2025-1239 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:22-cv-00434-RGA, Judge Richard G. Andrews. ______________________

ON MOTION ______________________

Before LOURIE, PROST, and CHEN, Circuit Judges. PER CURIAM. ORDER The parties notify the court that they have executed a settlement agreement resolving all claims and move at ECF Nos. 23 and 24 for dismissal of this appeal and Case: 25-1239 Document: 25 Page: 2 Filed: 09/29/2025

remand to the district court to amend the judgment con- sistent with its August 29, 2025 indicative ruling. Upon consideration thereof, IT IS ORDERED THAT: (1) The motions are granted to the extent that the ap- peal is remanded to the district court to rule on the parties’ motion to amend the final judgment, which this court leaves to the district court. See Ohio Willow Wood Co. v. Thermo-Ply, Inc., 629 F.3d 1374, 1375 (Fed. Cir. 2011). (2) The parties shall bear their own costs. FOR THE COURT

September 29, 2025 Date

ISSUED AS A MANDATE: September 29, 2025